ZHX2 Promotes HIF1α Oncogenic Signaling in Triple-Negative Breast Cancer
Wentong Fang(Jiangsu Province Hospital), Qing Zhang(Southwestern Medical Center), Weibo Luo(Southwestern Medical Center), Chengheng Liao(Southwestern Medical Center), Ujjawal Manocha(University of North Carolina at Chapel Hill), Giada Zurlo(University of North Carolina at Chapel Hill), Hong‐Rui Lin(National Tsing Hua University), Youqiong Ye(Shanghai Jiao Tong University), Rachel Shi(The University of Texas Southwestern Medical Center), Leng Han(Indiana University Health), Christopher Llynard D. Ortiz(National Tsing Hua University), Travis Ptacek(University of North Carolina at Chapel Hill), William Y. Kim(University of North Carolina at Chapel Hill), Jeremy M. Simon(Harvard University), Cheng Fan(University of North Carolina at Chapel Hill), Lee‐Wei Yang(National Tsing Hua University)
Cited by 0
Related Papers
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Evaluating the comparability of gene expression in blood and brain
|American Journal of Medical Genetics Part B Neuropsychiatric Genetics|2006|616